Bondre Mohammed Fayyadh, Al Qubtan Murtadha, Al Harthy Salim O
General Surgery, Royal Hospital, Muscat, OMN.
Gastroenterology, Royal Hospital, Muscat, OMN.
Cureus. 2022 Jul 19;14(7):e27011. doi: 10.7759/cureus.27011. eCollection 2022 Jul.
Colorectal cancer is among the most common cancers globally and carries a high mortality rate. The incidence of colorectal cancer has been increasing in the Middle East, including in Oman. While many countries have implemented a bowel cancer screening program, Oman has yet to establish one. A standard tool for bowel cancer screening is a fecal immunochemical test where a fecal sample is sent to a laboratory to check for blood content in the feces. In Oman, such fecal test kits are available at the primary health care level, but primary care physicians were unaware of the signs and symptoms or screening methods for colorectal cancer. This review article aims to assess the suitability of a colorectal cancer screening program in Oman using guidelines from the Supporting the Use of Research Evidence (SURE) collaboration.
结直肠癌是全球最常见的癌症之一，死亡率很高。中东地区，包括阿曼，结直肠癌的发病率一直在上升。虽然许多国家已经实施了肠癌筛查计划，但阿曼尚未建立。肠癌筛查的标准工具是粪便免疫化学检测，即将粪便样本送到实验室检查粪便中的血液含量。在阿曼，这种粪便检测试剂盒在初级卫生保健层面可用，但初级保健医生对结直肠癌的体征、症状或筛查方法并不了解。这篇综述文章旨在利用支持研究证据使用（SURE）合作组织的指南，评估阿曼结直肠癌筛查计划的适用性。
